Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
about
Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis.Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactamDaptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitroIn vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci.Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureusA synthetic congener modeled on a microbicidal domain of thrombin- induced platelet microbicidal protein 1 recapitulates staphylocidal mechanisms of the native moleculeMethicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.Synergism and the mechanism of action of the combination of α-mangostin isolated from Garcinia mangostana L. and oxacillin against an oxacillin-resistant Staphylococcus saprophyticus.Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.Molecular basis of in vivo biofilm formation by bacterial pathogensAnti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis.Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitroLB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.Diagnosis and management of community-associated MRSA infections in children.Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.Community case of methicillin-resistant Staphylococcus aureus infection.Macropis fulvipes Venom component Macropin Exerts its Antibacterial and Anti-Biofilm Properties by Damaging the Plasma Membranes of Drug Resistant Bacteria.Functional synergy of α-helical antimicrobial peptides and traditional antibiotics against Gram-negative and Gram-positive bacteria in vitro and in vivo.
P2860
Q33595252-21A90759-0DF8-46CE-98F5-FA534F283E42Q33977208-794FAC4D-F783-4FCA-9F53-3262073DE654Q33977947-D059325C-8BE2-4E37-A38F-9B21C1DD9262Q34045273-AE278B9B-8C98-4699-8D96-003D25D5E2DDQ34534007-3FCCEABE-8216-48E5-BDC2-143BB2A31A51Q35006670-AC397402-9BDD-497C-BD48-966AB5621450Q35121661-CE28BA32-CB06-417E-8CDE-61A39D5F4BD6Q35124432-E2E0B154-D39B-4691-8A2E-B3D2F74A9A81Q35127813-22A4E139-91C3-42C9-AFD9-B3D5CAF30641Q35376362-7D3CC70B-3612-4AA1-B302-07F8744A0F06Q36114756-8DCA57CE-31A3-4C12-B4CD-8DA907220E60Q36364106-094DA97A-85C5-46D0-8138-9E5B4AA05196Q36488561-A717EBA1-C78A-49D7-990B-9E0B72599915Q36880839-7F6C10D6-8200-4781-B062-4C9D50693F35Q36946145-44751A13-0AEE-4C78-BA06-81DDD935D57FQ37598693-47926673-F98C-4A07-ADEB-608E75A3598CQ37682916-CBB1EBD9-10A9-49B6-A1D4-D08308ED04CAQ39558119-E6BF114C-F4BC-4F36-84AE-09BA0765F8DDQ39650937-2BFE27FA-0C1A-43B4-897F-51A8CE6A9C57Q39779171-97ABA9B6-6C36-4A1C-8913-7242357B8209Q39865205-5878F784-055D-4137-9AAD-4709F46899A1Q41896430-B6C7FFC8-270A-4AE3-8D51-6B55FFB8283FQ42616851-654C2473-DAD6-45F0-8C17-145B8089FD74Q47117344-B5107444-4AAA-44E1-BF34-D8A5ED8E18E1Q54282937-02CA5DD9-C936-4546-BAC5-8348BFB1501D
P2860
Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Beta-Lactam-beta-lactamase-inh ...... illin-resistant staphylococci.
@en
type
label
Beta-Lactam-beta-lactamase-inh ...... illin-resistant staphylococci.
@en
prefLabel
Beta-Lactam-beta-lactamase-inh ...... illin-resistant staphylococci.
@en
P2860
P356
P1476
Beta-Lactam-beta-lactamase-inh ...... illin-resistant staphylococci.
@en
P2093
P2860
P304
P356
10.1128/AAC.35.4.685
P407
P577
1991-04-01T00:00:00Z